Table 2 of Dong, Mol Vis 2013; 19:1734-1746.
Cytokine | Patients with diabetes mellitus | Controls | P valuea | ||
---|---|---|---|---|---|
Median | Range | Median | Range | ||
IL-1β | 8.0 | 0–104 | 1.0 | 0–38 | <0.001 |
IL-1rα | 16.2 | 0–336 | 13.5 | 0–216 | 0.556 |
IL-2 | 1.6 | 0–108 | 1.8 | 0–126 | 0.868 |
IL-4 | 1.3 | 0–124 | 1.6 | 0–102 | 1.000 |
IL-5 | 1.1 | 0–141 | 2.4 | 0–161 | 0.812 |
IL-6 | 27.5 | 0–365 | 13.5 | 0–76 | <0.001 |
IL-7 | 4.6 | 0–89 | 2.1 | 0–76 | 0.123 |
IL-8 | 17.0 | 0–198 | 8.0 | 0–76 | <0.001 |
IL-9 | 3.6 | 0–187 | 2.8 | 0–98 | 0.575 |
IL-10 | 5.0 | 0–25 | 6.0 | 0–55 | 0.002 |
IL-12 | 8.0 | 0–46 | 10.0 | 0–105 | 0.013 |
IL-13 | 2.6 | 0–36 | 3.5 | 0–28 | 1.000 |
IL-15 | 2.3 | 0–56 | 1.6 | 0–86 | 0.768 |
IL-17 | - | - | - | - | - |
b-FGF | 12.6 | 0–165 | 9.1 | 0–78 | 0.654 |
Eotaxin | 6.5 | 0–95 | 5.1 | 0–112 | 1.000 |
G-CSF | - | - | - | - | - |
GM-CSF | 9.7 | 0–86 | 8.5 | 0–64 | 1.000 |
IFN-γ | - | - | - | - | - |
IP-10 | 4.0 | 0–76 | 1.0 | 0–6 | <0.001 |
MCP-1 | 385.5 | 58–2568 | 70.5 | 7–811 | <0.001 |
MIP-1α | - | - | - | - | - |
MIP-1β | 28.3 | 0–186 | 31.5 | 0–202 | 0.613 |
PDGF-BB | 3.2 | 0–46 | 4.5 | 0–61 | 0.716 |
RANTES | 4.6 | 0–76 | 5.2 | 0–67 | 1.000 |
TNF-α | - | - | - | - | - |
VEGF | 982.0 | 26–1888 | 66.0 | 11–676 | <0.001 |